|
AstraZeneca Pharma India Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
20271.25 Cr.
|
P/BV
|
23.23
|
Book Value (Rs.)
|
349.12
|
|
52 Week High/Low (Rs.)
|
9850/7552
|
FV/ML
|
2/1
|
P/E(X)
|
108.10
|
|
Bookclosure
|
31/07/2026
|
EPS (Rs.)
|
75.01
|
Div Yield (%)
|
0.44
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 75.01 | 46.30 | 64.60 | 39.70 | 24.60 |
| Diluted EPS (Rs.) | 75.01 | 46.30 | 64.60 | 39.70 | 24.60 |
| Cash EPS (Rs.) | 86.44 | 62.29 | 70.58 | 46.22 | 31.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 349.12 | 308.14 | 284.77 | 235.48 | 204.56 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 349.12 | 308.14 | 284.77 | 235.48 | 204.56 |
| Dividend / Share (Rs.) | 36.00 | 32.00 | 24.00 | 16.00 | 10.00 |
| Revenue From Operations / Share (Rs.) | 910.23 | 686.52 | 518.21 | 401.19 | 322.24 |
| PBDIT / Share (Rs.) | 116.21 | 117.84 | 87.70 | 76.49 | 40.38 |
| PBIT / Share (Rs.) | 104.78 | 101.84 | 81.72 | 69.98 | 33.60 |
| PBT / Share (Rs.) | 100.88 | 62.54 | 87.82 | 53.64 | 33.22 |
| Net Profit / Share (Rs.) | 75.01 | 46.30 | 64.60 | 39.72 | 24.64 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 12.76 | 17.16 | 16.92 | 19.06 | 12.52 |
| PBIT Margin (%) | 11.51 | 14.83 | 15.77 | 17.44 | 10.42 |
| PBT Margin (%) | 11.08 | 9.11 | 16.94 | 13.37 | 10.30 |
| Net Profit Margin (%) | 8.24 | 6.74 | 12.46 | 9.89 | 7.64 |
| Return on Networth / Equity (%) | 21.48 | 15.02 | 22.68 | 16.86 | 12.04 |
| Return on Capital Employeed (%) | 26.00 | 31.23 | 28.34 | 29.11 | 16.03 |
| Return On Assets (%) | 9.42 | 7.62 | 14.98 | 10.08 | 7.19 |
| Asset Turnover Ratio (%) | 1.30 | 1.32 | 1.26 | 1.09 | 0.98 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.77 | 1.91 | 2.61 | 2.18 | 2.12 |
| Quick Ratio (X) | 0.72 | 1.13 | 1.97 | 1.68 | 1.70 |
| Inventory Turnover Ratio (X) | 2.89 | 4.42 | 0.61 | 0.51 | 0.59 |
| Dividend Payout Ratio (NP) (%) | 42.66 | 51.84 | 24.76 | 20.14 | 8.11 |
| Dividend Payout Ratio (CP) (%) | 37.01 | 38.52 | 22.66 | 17.30 | 6.36 |
| Earning Retention Ratio (%) | 57.34 | 48.16 | 75.24 | 79.86 | 91.89 |
| Cash Earning Retention Ratio (%) | 62.99 | 61.48 | 77.34 | 82.70 | 93.64 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 64.70 | 201.78 | 182.71 | 303.52 | 106.25 |
| Interest Coverage Ratio (Post Tax) (%) | 43.93 | 146.57 | 121.90 | 222.46 | 65.84 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 18950.91 | 20979.18 | 12795.16 | 7617.77 | 5940.17 |
| EV / Net Operating Revenue (X) | 8.33 | 12.22 | 9.88 | 7.60 | 7.37 |
| EV / EBITDA (X) | 65.23 | 71.21 | 58.36 | 39.84 | 58.85 |
| MarketCap / Net Operating Revenue (X) | 8.52 | 12.54 | 10.27 | 8.09 | 7.93 |
| Retention Ratios (%) | 57.33 | 48.15 | 75.23 | 79.85 | 91.88 |
| Price / BV (X) | 22.23 | 27.93 | 18.68 | 13.79 | 12.49 |
| Price / Net Operating Revenue (X) | 8.52 | 12.54 | 10.27 | 8.09 | 7.93 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
